Short Interest in Bonk, Inc. (NASDAQ:BNKK) Expands By 761.1%

Bonk, Inc. (NASDAQ:BNKK) was the target of a significant increase in short interest in May. As of May 15th, there was short interest totaling 834,243 shares, an increase of 761.1% from the April 30th total of 96,882 shares. Approximately 21.5% of the shares of the stock are short sold. Based on an average trading volume of 724,730 shares, the days-to-cover ratio is presently 1.2 days.

Wall Street Analyst Weigh In

A number of equities analysts recently commented on the company. Wall Street Zen upgraded Bonk from a “sell” rating to a “hold” rating in a research report on Saturday, May 16th. Weiss Ratings cut Bonk from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Wednesday, April 29th. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the company presently has a consensus rating of “Sell”.

Bonk Trading Down 4.1%

NASDAQ:BNKK opened at $1.63 on Thursday. The firm has a market cap of $13.04 million, a PE ratio of -0.35 and a beta of 1.97. The stock has a fifty day moving average price of $2.47 and a 200 day moving average price of $3.59. Bonk has a 12-month low of $1.61 and a 12-month high of $46.90.

Bonk (NASDAQ:BNKK) last released its earnings results on Wednesday, May 13th. The company reported ($0.23) earnings per share (EPS) for the quarter. The company had revenue of $0.79 million during the quarter. Bonk had a negative net margin of 838.37% and a negative return on equity of 148.62%.

Insider Buying and Selling

In related news, Director Mitchell Austin Rudy acquired 31,055 shares of Bonk stock in a transaction that occurred on Thursday, April 9th. The shares were purchased at an average price of $2.82 per share, for a total transaction of $87,575.10. Following the completion of the transaction, the director owned 44,198 shares in the company, valued at $124,638.36. This represents a 236.29% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Insiders own 51.60% of the company’s stock.

Institutional Trading of Bonk

A number of institutional investors have recently bought and sold shares of the business. State Street Corp purchased a new stake in Bonk during the 4th quarter worth about $33,000. Jane Street Group LLC purchased a new stake in Bonk during the 4th quarter worth about $96,000. Steward Partners Investment Advisory LLC purchased a new stake in Bonk during the 4th quarter worth about $37,000. Finally, Geode Capital Management LLC purchased a new stake in Bonk during the 4th quarter worth about $128,000. 12.55% of the stock is owned by hedge funds and other institutional investors.

About Bonk

Safety Shot, Inc, a wellness and functional beverage company, engages in the research and development of over-the-counter products and intellectual property. Its products pipeline includes Photocil to address psoriasis and vitiligo; JW-700 to treat hair loss; JW-500 for women’s sexual wellness; NoStingz, a jellyfish sting prevention sunscreen; and JW-110 for the treatment of atopic dermatitis/eczema. The company primarily sell its products through third-party physical retail stores and partners. The company was formerly known as Jupiter Wellness, Inc and changed its name to Safety Shot, Inc in September 2023.